Induced pluripotent stem cells: challenges and opportunities for cancer immunotherapy.
Despite recent advances in cancer treatment over the past 30 years, therapeutic options remain limited and do not always offer a cure for malignancy. Given that tumor-associated antigens (TAA) are, by definition, self-proteins, the need to productively engage autoreactive T cells remains at the hear...
Hauptverfasser: | Sachamitr, P, Hackett, S, Fairchild, P |
---|---|
Format: | Journal article |
Sprache: | English |
Veröffentlicht: |
2014
|
Ähnliche Einträge
Ähnliche Einträge
-
Induced pluripotent stem cells: Challenges and opportunities for cancer immunotherapy
von: Patty eSachamitr, et al.
Veröffentlicht: (2014-04-01) -
Exploiting the use of induced pluripotent stem cell derived immune cells for immunotherapy
von: Sachamitr, S
Veröffentlicht: (2015) -
Directed differentiation of human induced pluripotent stem cells into dendritic cells displaying tolerogenic properties and resembling the CD141+ subset
von: Sachamitr, P, et al.
Veröffentlicht: (2018) -
Cross presentation of antigen by dendritic cells: mechanisms and implications for immunotherapy.
von: Sachamitr, P, et al.
Veröffentlicht: (2012) -
Directed Differentiation of Human Induced Pluripotent Stem Cells into Dendritic Cells Displaying Tolerogenic Properties and Resembling the CD141+ Subset
von: Patty Sachamitr, et al.
Veröffentlicht: (2018-01-01)